Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Clopidogrel, sold as the brandname Plavix among others, is an antiplatelet medication that is used to reduce the risk of heart disease and stroke in those at high risk. It is also used together with aspirin in heart attacks and following the placement of a coronary artery stent. It is taken by mouth.
Clopidogrel has remained, ever since its first approval in 1997, the antiplatelet therapy of choice among physicians for the treatment of patients with conditions such as acute coronary syndrome or percutaneous coronary intervention. The drug was the first thienopyridine to hit the market, which gave it an excellent head start over a number of drugs for these conditions that are either available in the market or are in clinical trials. As a result, the drug did not face much competition and has taken over the global market, with its array of application constantly expanding. The substantial and high-level evidence gathered over the years support the use of Clopidogrel for reduction of mortality and morbidity patients with acute coronary syndrome, myocardial infarction, and a number of other indications. As a result, the drug has developed a formidable presence in the global market over the years. Moreover, the drug’s relative ease of use, low rate of incidence of adverse reactions, and good tolerability have made it the de-facto antiplatelet agent for the reduction of atherosclerotic events in patients.These factors have helped the global Clopidogrel market to tread along an excellent growth path in the past few years and the market is expected to embark upon a healthy growth path in the next few years as well. However, the overall profitability of the market has reduced to a certain extent owing to entry of a number of generic products post the patent expiry of Clopidogrel manufacture in 2013. Nevertheless, the vast pool of patients prescribed Clopidogrel on an annual basis across the globe will allow market players excellent growth prospects in the next few years.
This report offers an overview of the market trends, drivers, and barriers with respect to the China Clopidogrel market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Clopidogrel market. Detailed analysis of key players, along with key growth strategies adopted by Clopidogrel industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Shenzhen Salubris Pharmaceuticals (China)
Lepu Medical Technology (China)
Sanofi (France)
By Type:
25mg
75 mg
300 mg
By End-User:
Hospitals
Private Clinics
Retail Pharmacies
Online Pharmacies
Others
By Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Clopidogrel Market
-
1.3 Market Segment by Type
-
1.3.1 China Clopidogrel Market Size and Growth Rate of 25mg from 2016 to 2027
-
1.3.2 China Clopidogrel Market Size and Growth Rate of 75 mg from 2016 to 2027
-
1.3.3 China Clopidogrel Market Size and Growth Rate of 300 mg from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 China Clopidogrel Market Size and Growth Rate of Hospitals from 2016 to 2027
-
1.4.2 China Clopidogrel Market Size and Growth Rate of Private Clinics from 2016 to 2027
-
1.4.3 China Clopidogrel Market Size and Growth Rate of Retail Pharmacies from 2016 to 2027
-
1.4.4 China Clopidogrel Market Size and Growth Rate of Online Pharmacies from 2016 to 2027
-
1.4.5 China Clopidogrel Market Size and Growth Rate of Others from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 North China Clopidogrel Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 Central China Clopidogrel Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 South China Clopidogrel Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 East China Clopidogrel Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.5 Northeast China Clopidogrel Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.6 Southwest China Clopidogrel Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.7 Northwest China Clopidogrel Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Clopidogrel Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Clopidogrel by Major Types
-
3.4.1 Market Size and Growth Rate of 25mg
-
3.4.2 Market Size and Growth Rate of 75 mg
-
3.4.3 Market Size and Growth Rate of 300 mg
4 Segmentation of Clopidogrel Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Clopidogrel by Major End-Users
-
4.4.1 Market Size and Growth Rate of Clopidogrel in Hospitals
-
4.4.2 Market Size and Growth Rate of Clopidogrel in Private Clinics
-
4.4.3 Market Size and Growth Rate of Clopidogrel in Retail Pharmacies
-
4.4.4 Market Size and Growth Rate of Clopidogrel in Online Pharmacies
-
4.4.5 Market Size and Growth Rate of Clopidogrel in Others
5 Market Analysis by Regions
-
5.1 China Clopidogrel Production Analysis by Regions
-
5.2 China Clopidogrel Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on China Economy
6 North China Clopidogrel Landscape Analysis
-
6.1 North China Clopidogrel Landscape Analysis by Major Types
-
6.2 North China Clopidogrel Landscape Analysis by Major End-Users
7 Central China Clopidogrel Landscape Analysis
-
7.1 Central China Clopidogrel Landscape Analysis by Major Types
-
7.2 Central China Clopidogrel Landscape Analysis by Major End-Users
8 South China Clopidogrel Landscape Analysis
-
8.1 South China Clopidogrel Landscape Analysis by Major Types
-
8.2 South China Clopidogrel Landscape Analysis by Major End-Users
9 East China Clopidogrel Landscape Analysis
-
9.1 East China Clopidogrel Landscape Analysis by Major Types
-
9.2 East China Clopidogrel Landscape Analysis by Major End-Users
10 Northeast China Clopidogrel Landscape Analysis
-
10.1 Northeast China Clopidogrel Landscape Analysis by Major Types
-
10.2 Northeast China Clopidogrel Landscape Analysis by Major End-Users
11 Southwest China Clopidogrel Landscape Analysis
-
11.1 Southwest China Clopidogrel Landscape Analysis by Major Types
-
11.2 Southwest China Clopidogrel Landscape Analysis by Major End-Users
12 Northwest China Clopidogrel Landscape Analysis
-
12.1 Northwest China Clopidogrel Landscape Analysis by Major Types
-
12.2 Northwest China Clopidogrel Landscape Analysis by Major End-Users
13 Major Players Profiles
-
13.1 Shenzhen Salubris Pharmaceuticals (China)
-
13.1.1 Shenzhen Salubris Pharmaceuticals (China) Company Profile and Recent Development
-
13.1.2 Market Performance
-
13.1.3 Product and Service Introduction
-
13.2 Lepu Medical Technology (China)
-
13.2.1 Lepu Medical Technology (China) Company Profile and Recent Development
-
13.2.2 Market Performance
-
13.2.3 Product and Service Introduction
-
13.3 Sanofi (France)
-
13.3.1 Sanofi (France) Company Profile and Recent Development
-
13.3.2 Market Performance
-
13.3.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure China Clopidogrel Market Size and Growth Rate of 25mg from 2016 to 2027
-
Figure China Clopidogrel Market Size and Growth Rate of 75 mg from 2016 to 2027
-
Figure China Clopidogrel Market Size and Growth Rate of 300 mg from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2021
-
Figure Market Share by Type in 2027
-
Figure China Clopidogrel Market Size and Growth Rate of Hospitals from 2016 to 2027
-
Figure China Clopidogrel Market Size and Growth Rate of Private Clinics from 2016 to 2027
-
Figure China Clopidogrel Market Size and Growth Rate of Retail Pharmacies from 2016 to 2027
-
Figure China Clopidogrel Market Size and Growth Rate of Online Pharmacies from 2016 to 2027
-
Figure China Clopidogrel Market Size and Growth Rate of Others from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2021
-
Figure Market Share by End-User in 2027
-
Figure North China Clopidogrel Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Central China Clopidogrel Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South China Clopidogrel Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure East China Clopidogrel Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast China Clopidogrel Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Southwest China Clopidogrel Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northwest China Clopidogrel Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Clopidogrel Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2020
-
Figure Market Share of TOP 5 Players in 2021
-
Figure Market Share of TOP 6 Players from 2016 to 2021
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Map of China
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Clopidogrel
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Clopidogrel by Different Types from 2016 to 2027
-
Table Consumption Share of Clopidogrel by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of 25mg
-
Figure Market Size and Growth Rate of 75 mg
-
Figure Market Size and Growth Rate of 300 mg
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Clopidogrel by Different End-Users from 2016 to 2027
-
Table Consumption Share of Clopidogrel by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Hospitals
-
Figure Market Size and Growth Rate of Private Clinics
-
Figure Market Size and Growth Rate of Retail Pharmacies
-
Figure Market Size and Growth Rate of Online Pharmacies
-
Figure Market Size and Growth Rate of Others
-
Table China Clopidogrel Production by Regions
-
Table China Clopidogrel Production Share by Regions
-
Figure China Clopidogrel Production Share by Regions in 2016
-
Figure China Clopidogrel Production Share by Regions in 2021
-
Figure China Clopidogrel Production Share by Regions in 2027
-
Table China Clopidogrel Consumption by Regions
-
Table China Clopidogrel Consumption Share by Regions
-
Figure China Clopidogrel Consumption Share by Regions in 2016
-
Figure China Clopidogrel Consumption Share by Regions in 2021
-
Figure China Clopidogrel Consumption Share by Regions in 2027
-
Table North China Clopidogrel Consumption by Types from 2016 to 2027
-
Table North China Clopidogrel Consumption Share by Types from 2016 to 2027
-
Figure North China Clopidogrel Consumption Share by Types in 2016
-
Figure North China Clopidogrel Consumption Share by Types in 2021
-
Figure North China Clopidogrel Consumption Share by Types in 2027
-
Table North China Clopidogrel Consumption by End-Users from 2016 to 2027
-
Table North China Clopidogrel Consumption Share by End-Users from 2016 to 2027
-
Figure North China Clopidogrel Consumption Share by End-Users in 2016
-
Figure North China Clopidogrel Consumption Share by End-Users in 2021
-
Figure North China Clopidogrel Consumption Share by End-Users in 2027
-
Table Central China Clopidogrel Consumption by Types from 2016 to 2027
-
Table Central China Clopidogrel Consumption Share by Types from 2016 to 2027
-
Figure Central China Clopidogrel Consumption Share by Types in 2016
-
Figure Central China Clopidogrel Consumption Share by Types in 2021
-
Figure Central China Clopidogrel Consumption Share by Types in 2027
-
Table Central China Clopidogrel Consumption by End-Users from 2016 to 2027
-
Table Central China Clopidogrel Consumption Share by End-Users from 2016 to 2027
-
Figure Central China Clopidogrel Consumption Share by End-Users in 2016
-
Figure Central China Clopidogrel Consumption Share by End-Users in 2021
-
Figure Central China Clopidogrel Consumption Share by End-Users in 2027
-
Table South China Clopidogrel Consumption by Types from 2016 to 2027
-
Table South China Clopidogrel Consumption Share by Types from 2016 to 2027
-
Figure South China Clopidogrel Consumption Share by Types in 2016
-
Figure South China Clopidogrel Consumption Share by Types in 2021
-
Figure South China Clopidogrel Consumption Share by Types in 2027
-
Table South China Clopidogrel Consumption by End-Users from 2016 to 2027
-
Table South China Clopidogrel Consumption Share by End-Users from 2016 to 2027
-
Figure South China Clopidogrel Consumption Share by End-Users in 2016
-
Figure South China Clopidogrel Consumption Share by End-Users in 2021
-
Figure South China Clopidogrel Consumption Share by End-Users in 2027
-
Table East China Clopidogrel Consumption by Types from 2016 to 2027
-
Table East China Clopidogrel Consumption Share by Types from 2016 to 2027
-
Figure East China Clopidogrel Consumption Share by Types in 2016
-
Figure East China Clopidogrel Consumption Share by Types in 2021
-
Figure East China Clopidogrel Consumption Share by Types in 2027
-
Table East China Clopidogrel Consumption by End-Users from 2016 to 2027
-
Table East China Clopidogrel Consumption Share by End-Users from 2016 to 2027
-
Figure East China Clopidogrel Consumption Share by End-Users in 2016
-
Figure East China Clopidogrel Consumption Share by End-Users in 2021
-
Figure East China Clopidogrel Consumption Share by End-Users in 2027
-
Table Northeast China Clopidogrel Consumption by Types from 2016 to 2027
-
Table Northeast China Clopidogrel Consumption Share by Types from 2016 to 2027
-
Figure Northeast China Clopidogrel Consumption Share by Types in 2016
-
Figure Northeast China Clopidogrel Consumption Share by Types in 2021
-
Figure Northeast China Clopidogrel Consumption Share by Types in 2027
-
Table Northeast China Clopidogrel Consumption by End-Users from 2016 to 2027
-
Table Northeast China Clopidogrel Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast China Clopidogrel Consumption Share by End-Users in 2016
-
Figure Northeast China Clopidogrel Consumption Share by End-Users in 2021
-
Figure Northeast China Clopidogrel Consumption Share by End-Users in 2027
-
Table Southwest China Clopidogrel Consumption by Types from 2016 to 2027
-
Table Southwest China Clopidogrel Consumption Share by Types from 2016 to 2027
-
Figure Southwest China Clopidogrel Consumption Share by Types in 2016
-
Figure Southwest China Clopidogrel Consumption Share by Types in 2021
-
Figure Southwest China Clopidogrel Consumption Share by Types in 2027
-
Table Southwest China Clopidogrel Consumption by End-Users from 2016 to 2027
-
Table Southwest China Clopidogrel Consumption Share by End-Users from 2016 to 2027
-
Figure Southwest China Clopidogrel Consumption Share by End-Users in 2016
-
Figure Southwest China Clopidogrel Consumption Share by End-Users in 2021
-
Figure Southwest China Clopidogrel Consumption Share by End-Users in 2027
-
Table Northwest China Clopidogrel Consumption by Types from 2016 to 2027
-
Table Northwest China Clopidogrel Consumption Share by Types from 2016 to 2027
-
Figure Northwest China Clopidogrel Consumption Share by Types in 2016
-
Figure Northwest China Clopidogrel Consumption Share by Types in 2021
-
Figure Northwest China Clopidogrel Consumption Share by Types in 2027
-
Table Northwest China Clopidogrel Consumption by End-Users from 2016 to 2027
-
Table Northwest China Clopidogrel Consumption Share by End-Users from 2016 to 2027
-
Figure Northwest China Clopidogrel Consumption Share by End-Users in 2016
-
Figure Northwest China Clopidogrel Consumption Share by End-Users in 2021
-
Figure Northwest China Clopidogrel Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Shenzhen Salubris Pharmaceuticals (China)
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Shenzhen Salubris Pharmaceuticals (China)
-
Figure Sales and Growth Rate Analysis of Shenzhen Salubris Pharmaceuticals (China)
-
Figure Revenue and Market Share Analysis of Shenzhen Salubris Pharmaceuticals (China)
-
Table Product and Service Introduction of Shenzhen Salubris Pharmaceuticals (China)
-
Table Company Profile and Development Status of Lepu Medical Technology (China)
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Lepu Medical Technology (China)
-
Figure Sales and Growth Rate Analysis of Lepu Medical Technology (China)
-
Figure Revenue and Market Share Analysis of Lepu Medical Technology (China)
-
Table Product and Service Introduction of Lepu Medical Technology (China)
-
Table Company Profile and Development Status of Sanofi (France)
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi (France)
-
Figure Sales and Growth Rate Analysis of Sanofi (France)
-
Figure Revenue and Market Share Analysis of Sanofi (France)
-
Table Product and Service Introduction of Sanofi (France)
-
